1335300-06-5

Basic information

• Product Name: azetidin-1-yl(1-Methyl-1H-pyrazol-4-yl)Methanone
• Synonyms: azetidin-1-yl(1-Methyl-1H-pyrazol-4-yl)Methanone
• CAS NO: 1335300-06-5
• Molecular Formula: C₈H₁₁N₃O
• Molecular Weight: 165.19244
• Mol File: 1335300-06-5.mol
• Article Data: 3

Chemical Properties

• Appearance: /
• CAS DataBase Reference: azetidin-1-yl(1-Methyl-1H-pyrazol-4-yl)Methanone(CAS DataBase Reference)
• NIST Chemistry Reference: azetidin-1-yl(1-Methyl-1H-pyrazol-4-yl)Methanone(1335300-06-5)
• EPA Substance Registry System: azetidin-1-yl(1-Methyl-1H-pyrazol-4-yl)Methanone(1335300-06-5)

Safety Data

• Hazardous Substances Data: 1335300-06-5(Hazardous Substances Data)

Upstream product

• 503-29-7 azetidine 
• 5952-92-1 1-methyl-1H-pyrazole-4-carboxylic acid 

Downstream Products

• 1278407-70-7 4-(azetidine-1-carbonyl)-2-methyl-2H-pyrazole-3-carboxylic acid 
• 1335300-20-3 4-(azetidine-1-carbonyl)-N-(2-(3-(fluoromethoxy)phenyl)imidazo[1,2-a]pyrimidin-7-yl)-1-methyl-1H-pyrazole-5-carboxamide 

Relevant articles and documents

TRIAZOLOPYRIDINE COMPOUNDS

The invention is concerned with triazolopyridine compounds of formula (I) wherein R1, R2, R3 and R4 are as defined in the description and in the claims, as well as physiologically acceptable salts thereof. These

N-(IMIDAZOPYRIMIDIN-7-YL)-HETEROARYLAMIDE DERIVATIVES AND THEIR USE AS PDE10A INHIBITORS

The invention is concerned with novel imidazopyrimidine derivatives of formula (I) wherein R1, R2 and R8 are as defined in the description and in the claims, as well as physiologically acceptable salts and esters thereof. These compounds inhibit PDEIOA and used as medicaments.